Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

NCT01690533 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01690533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01690533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 13, 2008
Completion date
July 19, 2013
Enrollment
497 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-infective agents